Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.29 NOK | +4.23% | +5.52% | -28.55% |
06-20 | Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting | CI |
06-11 | Nykode Therapeutics ASA Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.55% | 469M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- VACC Stock
- News Nykode Therapeutics
- Transcript : Nykode Therapeutics AS, Q1 2023 Earnings Call, May 12, 2023